Cannabis drugs helpful in MS, not in other neurological conditionsBut research review finds few studies of smoked marijuana Uric acid: Stroke treatment?Study opens ‘a completely fresh approach’ Vaccinations protect against childhood stroke Infections a preventable risk factor, study shows COPD bad for the brain Managing bacterial meningitis in children Updated statement outlines empiric antimicrobial therapy and clarifies the role of corticosteroids. Alemtuzumab for multiple sclerosis rejected by U.S. FDA Neurologists divided over the FDA’s decision. Lemtrada: new treatment for relapsing remitting MS Two treatment courses reduce relapse risk and disability accumulation. Updated Canadian statement on the use of herpes zoster vaccine New statement provides clarity on several controversial issues. Alzheimer risk starts early Aubagio: new oral therapy for MS Drug approved for use as a monotherapy to reduce the frequency of clinical exacerbations, delay accumulation of physical disability. First Previous 30 31 32 33 34 Next Last
